Literature DB >> 26136877

Effects of anesthesia on conventional and speckle tracking echocardiographic parameters in a mouse model of pressure overload.

Guan Wang1, L E Zhang1, Anne Manyande2, Ming Cao1, Wei He1, Xiaofen Wu1, Jinli Wang1, Cuntai Zhang1.   

Abstract

Genetically-modified mice are widely applied in cardiovascular studies as model organisms. Echocardiography is a key tool for evaluating cardiac and hemodynamic functions in mice. The present study aimed to examine the effects of isoflurane (ISF) on conventional and speckle tracking echocardiography (STE) parameters under healthy and pathological conditions using a murine model of pressure overload. In addition, the optimal dose of ISF in the process of echocardiographic measurement, with minimum cardiac contraction depression, was investigated. Conventional echocardiographic and STE examinations were performed on 38 adult C57BL/6 male mice. The mice were divided into the following three groups: The sham (n=15); mild thoracic aortic banding (TAB; n=15); and severe TAB (n=8) groups. ISF was administered under deep anesthesia (DA; 1-2% ISF), light anesthesia (LA; 0.5-1% ISF) and immediately prior to the mice waking up (awake; 0-0.5% ISF). Conventional echocardiographic parameters were preserved within the sham and mild TAB groups (P>0.05 for each parameter) under LA and awake conditions. However, under DA conditions, the majority of these parameters were reduced compared with the LA and awake conditions (P<0.05). In the severe TAB group, conventional echocardiographic parameters remained constant under LA, DA and awake conditions. STE parameters in the groups remained similar between the LA and awake conditions, but were significantly reduced under DA conditions. Therefore, conventional echocardiography and STE may be performed using LA induced with low doses of ISF, under various pathological conditions without affecting cardiac function.

Entities:  

Keywords:  echocardiography; heart failure; hypertrophy; left ventricular function; mouse

Year:  2015        PMID: 26136877      PMCID: PMC4471799          DOI: 10.3892/etm.2015.2331

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  29 in total

1.  Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate.

Authors:  Frank Weidemann; Fadi Jamal; George R Sutherland; Piet Claus; Miroslaw Kowalski; Liv Hatle; Ivan De Scheerder; Bart Bijnens; Frank E Rademakers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

Review 2.  Assessment of subendocardial structure and function.

Authors:  Tony Stanton; Thomas H Marwick
Journal:  JACC Cardiovasc Imaging       Date:  2010-08

3.  Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload.

Authors:  Aziz Guellich; Shumin Gao; Chull Hong; Lin Yan; Thomas E Wagner; Sunil K Dhar; Bijan Ghaleh; Luc Hittinger; Kosaku Iwatsubo; Yoshihiro Ishikawa; Stephen F Vatner; Dorothy E Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-18       Impact factor: 4.733

Review 4.  Echocardiographic strain imaging and its use in the clinical setting.

Authors:  Caroline Cottrell; James N Kirkpatrick
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-01

5.  Impact of anesthesia on cardiac function during echocardiography in mice.

Authors:  David M Roth; James S Swaney; Nancy D Dalton; Elizabeth A Gilpin; John Ross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

6.  Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsalpha.

Authors:  M Uechi; K Asai; M Osaka; A Smith; N Sato; T E Wagner; Y Ishikawa; H Hayakawa; D E Vatner; R P Shannon; C J Homcy; S F Vatner
Journal:  Circ Res       Date:  1998-03-09       Impact factor: 17.367

7.  Effects of isoflurane concentration on basic echocardiographic parameters of the left ventricle in rats.

Authors:  H Ríha; F Papoušek; J Neckář; J Pirk; B Ošťádal
Journal:  Physiol Res       Date:  2012-06-06       Impact factor: 1.881

8.  Comparison of newly developed inhalation anesthesia system and intraperitoneal anesthesia on the hemodynamic state in mice.

Authors:  Yoshikazu Matsuda; Kazumasa Ohsaka; Hidekazu Yamamoto; Katsuhiko Natsume; Shirokazu Hirabayashi; Masayoshi Kounoike; Masaaki Inoue
Journal:  Biol Pharm Bull       Date:  2007-09       Impact factor: 2.233

9.  Influence of heart rate on myocardial function using two-dimensional speckle-tracking echocardiography in healthy dogs.

Authors:  Ryohei Suzuki; Hirotaka Matsumoto; Takahiro Teshima; Hidekazu Koyama
Journal:  J Vet Cardiol       Date:  2013-05-02       Impact factor: 1.701

10.  Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.

Authors:  Olivier Lairez; Denis Calise; Pascale Bianchi; Catherine Ordener; Odile Spreux-Varoquaux; Céline Guilbeau-Frugier; Ghislaine Escourrou; Isabelle Seif; Jérôme Roncalli; Nathalie Pizzinat; Michel Galinier; Angelo Parini; Jeanne Mialet-Perez
Journal:  J Mol Cell Cardiol       Date:  2009-01-07       Impact factor: 5.000

View more
  3 in total

1.  Ivabradine improved left ventricular function and pressure overload-induced cardiomyocyte apoptosis in a transverse aortic constriction mouse model.

Authors:  Yihui Yu; Zuoying Hu; Bing Li; Zhimei Wang; Shaoliang Chen
Journal:  Mol Cell Biochem       Date:  2018-05-22       Impact factor: 3.396

2.  The relationship between miRNA-26b and connective tissue growth factor in rat models of aortic banding and debanding.

Authors:  Jung Sun Cho; Jongho Lee; Ki Cheol Park; Keum-Jin Yang; Eun Joo Cho
Journal:  Korean J Intern Med       Date:  2019-12-30       Impact factor: 2.884

3.  Myocardial contrast echocardiography assessment of mouse myocardial infarction: comparison of kinetic parameters with conventional methods.

Authors:  Nicholas T Thielen; Adison A Kleinsasser; Jessica L Freeling
Journal:  PeerJ       Date:  2021-06-01       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.